New guidance on regulatory pathways for personalized medical devices

International Medical Devices Regulators Forum releases final guidance document

The International Medical Device Regulators Forum (IMDRF) is a  voluntary group of medical device regulators from around the world.  They have recently issued a final guidance document - Personalized Medical Devices – Regulatory Pathways.  The purpose of the guidance is to:

  • recommend a harmonized approach for the application of existing regulatory requirements for medical devices that are intended for a particular individual; and,
  • identify special considerations for the regulation of identified categories of personalized medical device.

This guidance also provides an overview of considerations and concepts that could be relevant in developing a harmonised assessment approach in future.

Many jurisdictions define the term custom-made device. Custom-made devices are intended:

  • for the sole use of a particular individual; and,
  • to be made in accordance with a written request of an authorized healthcare professional; and,
  • to address specific anatomo-physiological features or pathological condition of the individual for whom it is intended.

The regulatory requirements have introduced exemptions for regulating custom-made medical devices in order to cover situations where commercially available devices are inadequate for the needs and requirements of a particular individual.  These exemptions have been based on premises that affected devices would:

  • be used only in special cases and so the numbers of manufactured custom-made devices would be low; and,
  • largely comprise low-risk products or limited use of higher-risk implantable devices.

However, technological development has meant that it is now possible to manufacture individualized medical devices in a completely different manner from the skilled, manual processes that were originally envisaged. Computer-controlled additive and subtractive manufacturing methods (often called 3-D printing) can be used to create personalized medical devices based on digital patient data, potentially with the manufacturing activity undertaken at the point-of-care. Growing numbers of patients are receiving these medical devices to meet their particular needs.

This recent guidance builds on a previous IMDRF document Definitions for Personalized Medical Devices. As well as custom-made medical device, the additional terms patient-matched and ‘adaptable’ medical device are introduced. These devices are designed and produced under the responsibility of a manufacturer, where:

  • adaptable medical devices are mass-produced and adapted, shaped or assembled at the point-of care in accordance with specific patient’s specific anatomo-physiologic features following the manufacturer’s instructions; whereas,
  • patient-matched medical devices are scaled within a specified design window using anatomic references or anatomical features from patient imaging.

The guidance document gives a flowchart describing how to classify a device into these three categories of personalized medical devices. It provides recommendations for custom-made, patient-matched and adaptable medical devices. Two annexes provide considerations for personalized devices:

  • produced using additive or subtractive manufacturing; and,
  • manufactured at point-of care.

This guidance will be relevant to manufacturers producing personalized medical devices or looking into additive or subtractive manufacturing technology or point-of-care manufacturing.

Author: Eamonn Hoxey, of E V Hoxey Ltd, UK, is a writer, trainer and consultant on a range of life science areas including regulatory compliance, quality management, sterility assurance and standards development

Request more information today for a call back from a member of our sales team so that you can get a better understanding of how Compliance Navigator can meet your needs.  

The Compliance Navigator blog is issued for information only. It does not constitute an official or agreed position of BSI Standards Ltd or of the BSI Notified Body.  The views expressed are entirely those of the authors.